Federation des caisses Desjardins du Quebec’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,315
Closed -$846 2400
2023
Q1
$846 Hold
1,315
﹤0.01% 2173
2022
Q4
$1.1K Buy
1,315
+1,150
+697% +$1.68K ﹤0.01% 2272
2022
Q3
$230 Hold
165
﹤0.01% 2442
2022
Q2
$673 Hold
165
﹤0.01% 2423
2022
Q1
$1.08K Sell
165
-240
-59% -$2K ﹤0.01% 2423
2021
Q4
$4.89K Hold
405
﹤0.01% 2206
2021
Q3
$9.07K Buy
+405
New +$10.2K ﹤0.01% 2072

Other funds holding REUN

Federation des caisses Desjardins du Quebec's REUN Position: Q2 2023 in Review

Federation des caisses Desjardins du Quebec sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q2 2023, closing a stake of 1,315 shares — an estimated $846 sold.

Federation des caisses Desjardins du Quebec first reported a position in REUN in Q3 2021 and held it in 7 quarters. The position peaked at $9.07K in Q3 2021. 21 funds tracked by Wall St. Rank hold REUN as of Q2 2023.

  • Federation des caisses Desjardins du Quebec reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q2 2023 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 1,315 Reunion Neuroscience Inc. Common Shares shares in Q2 2023, an estimated $846.
  • Federation des caisses Desjardins du Quebec first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 7 quarters.
  • Federation des caisses Desjardins du Quebec's Reunion Neuroscience Inc. Common Shares position peaked at $9.07K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q2 2023.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2023, filed 15 Aug 2024.